TL;DR: SAFE vs Convertible Note in 2026, and Which One Protects Your Cap Table
If you are weighing SAFE vs Convertible Note in 2026, pick the instrument that fits your jurisdiction, your timeline, and your investors, not the one that is fashionable.
Your choice of funding instrument is probably based on fashion, not math.
- The numbers: A $300,000 convertible note at 6% interest over 18 months converts into 654,000 shares. The same check as a SAFE converts into 600,000 shares. That is 9% more equity for the same cash. Notes commonly carry 4% to 8% annual interest and a maturity date that can turn into a repayment demand.
- A SAFE usually fits US pre-seed founders: It has no interest, no maturity date, and no repayment obligation. Carta data shows that 92% of pre-seed rounds use SAFEs (see these pre-seed funding statistics). Watch for one trap. Each new post-money SAFE dilutes you, not your earlier investors.
- A convertible note usually fits bridges and European companies: Choose a note when your priced round is 6 to 12 months away. A note also makes sense when your Dutch BV or German GmbH makes convertible loans the local norm. UK founders often use ASAs instead, and French founders use the BSA AIR.
The full guide by Violetta Bonenkamp (Mean CEO) includes a weighted scorecard, the FITS decision framework, the ways each instrument fails, and a 30-day validation plan. Before you sign anything, set a defensible valuation cap. Then spend 45 minutes modeling your raise two ways: as a SAFE and as a note at 6% interest. Run each with your Series A on time, 6 months late, and 12 months late. Your ownership in those six cells will show you which paper to sign.
Check out latest news, stats and trends that you might like:
AI News | November, 2026 (STARTUP EDITION)
The SAFE vs Convertible Note decision looks like paperwork, and that is exactly why so many founders get it wrong. Both instruments let you raise money WITHOUT setting a valuation today, and both convert into shares at a future priced round. They behave very differently when things go sideways, when your round takes longer than planned, or when your investors start asking for their money back. I am Violetta Bonenkamp, also known as Mean CEO. I am a European parallel entrepreneur behind CADChain and Fe/male Switch, with an MBA and more than 20 years of international work. I have sat on the founder side of grant applications, accelerator programs, and investor conversations across Europe. This guide gives you the numbers, the traps, and a decision framework you can use this week.
Here is my provocative opening position: most founders pick a SAFE because it is fashionable, and most investors push a convertible note because it is safer for them. Neither reason is good enough. Let’s break it down.
What Is the Quick Verdict on SAFE vs Convertible Note in 2026?
Choose a SAFE if you are a US-incorporated (usually Delaware) startup raising a small, fast pre-seed or seed round and your timeline to a priced round is uncertain. Choose a convertible note if your investors demand downside protection, your company sits in a jurisdiction where SAFEs are legally awkward, or you are bridging to a round you expect to close within 12 to 18 months. For early-stage US founders with angel investors, the SAFE is the stronger default because it carries NO interest, NO maturity date, and NO repayment obligation.
The right choice depends most on three factors: your jurisdiction, your expected time to a priced round, and who holds the bargaining power in your raise. A European founder with a Dutch BV or German GmbH faces a very different answer than a Delaware C-Corp in San Francisco.
How Do SAFEs and Convertible Notes Compare at a Glance?
The table below compares both instruments across 12 decision criteria. Ratings marked as judgments are my editorial view, based on the 2026 sources cited throughout this article.
| Criterion | SAFE | Convertible Note | Better for |
|---|---|---|---|
| Best suited to | Fast pre-seed and seed rounds, US startups | Bridge rounds, cautious investors, non-US structures | Depends |
| Main advantage | No interest, no maturity, no debt | Investor protection and creditor rights | Founder: SAFE / Investor: Note |
| Main limitation | Can sit outstanding indefinitely; dilution surprises | Maturity deadline and repayment risk | Context |
| Interest cost (2026) | 0% | Commonly 4% to 8% per year | SAFE |
| Typical discount | 10% to 25% (or cap only in YC post-money SAFE) | 10% to 25%, plus cap | Tie |
| Time and legal cost to document | Lower (fewer negotiable fields) | Higher (interest, maturity, repayment terms) | SAFE |
| Balance sheet treatment | Not debt | Liability until conversion | SAFE |
| Control and flexibility (judgment) | High for founders | Higher for investors | Depends |
| Ranking if the company fails | Behind all debt, ahead of common equity | Ahead of SAFE holders and equity | Investor: Note |
| EU considerations | US instrument; needs local adaptation | Convertible loans are familiar in many EU countries | EU: Note (often) |
| Best for bootstrappers taking a first check | Strong fit | Riskier due to repayment obligation | SAFE |
| Overall verdict (judgment) | Founder-friendly default in the US | Structured choice for bridges and cautious capital | Conditional |
What Are a SAFE and a Convertible Note?
What is a SAFE?
A SAFE (Simple Agreement for Future Equity) is a contract that gives an investor the right to receive shares when a triggering event happens, usually your next priced equity round, an acquisition, or dissolution. Y Combinator introduced it as a simpler alternative to the convertible note. A SAFE is NOT debt: it has no interest rate, no maturity date, and you cannot technically default on it. As the LearnSignal guide to SAFE notes and convertible notes explains, stripping out debt mechanics makes it faster and cheaper to document, which is why it became the default for US seed rounds.
What is a convertible note?
A convertible note is a short-term loan designed to turn into equity, usually at your next priced round. It sits on your balance sheet as a liability, accrues interest, and carries a maturity date. At conversion, the principal plus accrued interest turns into preferred shares. If no conversion happens by maturity, the investor can ask for repayment, renegotiate, or extend. Investors like it because it is a familiar, structured instrument with creditor rights.
What is the fundamental difference?
A SAFE optimizes for founder speed and flexibility, while a convertible note optimizes for investor protection and a forced resolution date.
They are direct substitutes for the same job: raising early capital before a priced round. They are not identical. A SAFE is a promise of future shares. A note is a loan with an exit door into shares. The Holon Law comparison of SAFEs, convertible notes, and priced rounds adds a third option worth remembering: the priced round, which issues equity immediately at an agreed valuation.
How Was This Comparison Made?
- Evaluation date: 2026, using sources published or updated in 2026.
- Evidence used: legal and fintech guides from LearnSignal, Aspire, Promise Legal, Holon Law, Cake Equity, Carta, Qubit Capital, Stripe, Thienel Law, and PandaDoc, plus my own recalculation of their worked examples.
- Test scenario: a pre-seed startup raising between $300,000 and $1,000,000 before a Series A.
- Criteria and weighting: dilution, downside risk, speed and cost, investor appetite, jurisdiction fit, and tax treatment. Dilution and downside risk weigh most.
- Geographic scope: most data comes from the US market. I flag where it does not transfer to European founders.
- Commercial disclosure: no affiliation with any source or platform mentioned.
- Limitations: interest rates and deal terms shift with market conditions; this is not legal or tax advice.
Which Decision Criteria Actually Matter for Founders?
Founders often compare these instruments on “which one is simpler.” That question is too shallow. Here is why: simplicity at signing can hide complexity at conversion. The six criteria below change real outcomes for your cap table, runway, and relationships.
- Dilution at conversion, because interest and stacking change how much of your company you keep.
- Downside and default risk, because a maturity date can turn into a cash demand.
- Speed and documentation cost, because founder hours and legal fees burn runway.
- Investor appetite and bargaining power, because the best instrument is useless if nobody signs it.
- Jurisdiction fit, because a US template does not plug into EU company law.
- Tax treatment for investors, because tax friction affects who wants to invest on which terms.
Which Instrument Dilutes Founders More?
Dilution matters because every percentage point you give away early is gone forever, and it compounds through every future round. Let’s use the worked example published by Aspire’s 2026 guide to SAFE vs convertible notes for seed funding.
- Investment: $300,000 with a $6 million valuation cap.
- Series A: $12 million pre-money, priced at $1.00 per share.
- Conversion price thanks to the cap: $0.50 per share.
- SAFE investor: $300,000 ÷ $0.50 = 600,000 shares.
- Note investor (6% interest over 18 months): $327,000 ÷ $0.50 = 654,000 shares.
That is 54,000 extra shares, or 9% more equity, going to the note holder for the exact same cash. On a bigger raise, the gap grows. Qubit Capital’s guide to convertible debt and SAFE notes estimates that a SAFE saves roughly $60K to $80K of equity on a $1M raise over 18 months at 6% to 8% interest. My own recalculation with simple interest gives a larger number: $90K at 6% and $120K at 8% over 18 months. Their range matches roughly 12 months of accrual. Either way, the direction is clear and the cost is real.
Now the uncomfortable part. SAFEs have their own dilution trap. Stripe’s explainer on convertible notes vs SAFEs points out that post-money SAFEs fix the investor’s ownership percentage, so every additional SAFE dilutes the founders, not earlier SAFE holders. Founders who stack five or six SAFEs often discover at Series A that they own far less than they assumed.
- SAFE: no interest dilution, but stacked post-money SAFEs hit founders directly.
- Convertible note: interest inflates the converting amount every month the round is delayed.
- Key trade-off: the note punishes slow timelines; the SAFE punishes careless stacking.
- Winner: SAFE, for founders who model their cap table before every new check.
- Confidence: High, because the math is transparent and reproducible.
What Happens If You Never Raise a Priced Round?
Downside risk matters because roughly speaking, most startups do not follow the planned fundraising script. Rounds slip, markets cool, and pivots happen. This criterion decides whether a delay is an inconvenience or a crisis.
- SAFE: no maturity date and no repayment obligation, even if the business never raises again. It can stay outstanding indefinitely. That protects your cash, and it can also leave a messy overhang on your cap table.
- Convertible note: the maturity date forces a resolution through conversion, repayment, or renegotiation. Because it is debt, the holder has creditor rights, which matter if the company runs into financial trouble before conversion.
- Ranking at failure: according to Thienel Law’s SAFE vs convertible note comparison, note holders rank ahead of SAFE holders and equity holders, while SAFE holders rank behind all debt holders but ahead of common equity and founders.
- Key trade-off: SAFEs shift risk to investors; notes shift risk back to founders.
- Winner: SAFE for founders; convertible note for investors.
- Confidence: High.
My take as Mean CEO: I have watched founders treat a maturity date like a far-away abstraction. Then month 17 arrives, the Series A has not closed, and the founder spends three weeks negotiating extensions instead of selling. A maturity date is a CALENDAR WEAPON. Know who holds it.
Which One Is Faster and Cheaper to Close?
Speed matters because founder hours are your scarcest currency at pre-seed. Every week spent negotiating terms is a week not spent with customers.
- SAFE: fewer fields to negotiate. Thienel Law notes that usually only the valuation cap or discount is negotiable, and Qubit Capital notes that online platforms need far fewer fields for SAFEs.
- Convertible note: interest rate, maturity date, repayment terms, conversion triggers, and default provisions are all on the table. Many terms are negotiable, so they cost more to negotiate.
- Winner: SAFE.
- Confidence: High in the US; Medium in Europe, where local law adds steps to both instruments.
How Do Valuation Caps, Discounts, and MFN Clauses Work in Each?
This is where most confusion lives, so here are the mechanics in plain language.
- Valuation cap: a ceiling on the valuation used for conversion. If your Series A prices above the cap, early investors still convert at the cap. Both instruments can include one. Cake Equity’s founder guide to SAFE vs convertible note describes how the cap places a ceiling on the conversion valuation.
- Discount rate: a percentage off the next round’s share price, typically 10% to 25%, per Promise Legal’s 2026 term-by-term guide.
- Cap OR discount: in YC’s post-money SAFE framework, you choose a cap or a discount, not both. Negotiated SAFEs sometimes include both, with the investor getting whichever is better.
- Convertible notes: the investor usually gets the lower of the capped price or the discounted price.
- MFN (Most Favored Nation) provision: lets an early investor adopt better terms you give to later investors in the same instrument class. Uncapped SAFEs often carry MFN clauses.
Quick example: your Series A prices at $2.00 per share. A 20% discount gives $1.60. A cap that implies $1.20 gives $1.20. On a note with both, the investor converts at $1.20, the lower price. On a standard YC SAFE with a cap only, the investor also converts at $1.20, and no discount applies.
Do Investors Prefer SAFEs or Convertible Notes?
Investor appetite matters because an instrument nobody will sign raises exactly zero euros. PandaDoc’s guide on convertible notes vs SAFEs notes that SAFEs are more popular in startup environments thanks to faster fundraising, while convertible notes may be preferred by investors because they carry less risk and clearer predefined terms.
- SAFE: accepted by US accelerators, many angels, and seed funds familiar with YC paperwork.
- Convertible note: preferred by traditional angels, family offices, and investors outside Silicon Valley who want debt protection.
- Winner: Depends on who sits across the table.
- Confidence: Medium, since preferences vary by region and investor type.
How Does Tax Treatment Differ?
Tax matters because investor after-tax returns shape the terms they ask for. In the US, Qubit Capital points out that note interest is taxed as ordinary income, up to 37% federally, while long-term capital gains often run 15% to 20%. On $500K of note interest, that gap can cost an investor $85K to $100K in extra tax. Surprising outcome: the interest that “protects” note investors can be tax-inefficient for them.
Transferability note: these figures are US federal rates. European tax regimes differ by country, and in some EU states the debt character of a convertible loan has its own accounting and withholding consequences. Speak to a local tax adviser before assuming anything.
What Does This Look Like in a Real Founder Scenario?
The scenario
- Company: a B2B SaaS startup at pre-seed, with first paying pilots.
- Team: two founders, one technical, using no-code tools for operations.
- Budget: raising $500,000 from four angels.
- Goal: reach Series A readiness within 18 to 24 months.
- Constraints: uncertain sales cycle; enterprise pilots can stall.
How the SAFE performs
Closing takes days using standard templates. The $500,000 converts at the cap with no growth from interest. If the Series A slips from month 18 to month 26, nothing changes for the founders. The risk is stacking: if the founders add two more SAFEs at higher caps, they need to model the combined post-money dilution before each signature.
How the convertible note performs
At 6% simple interest, the converting amount reaches about $545,000 at month 18 and $565,000 at month 26. If maturity is set at 18 months, the founders must negotiate an extension at the exact moment they are weakest: mid-raise, with low cash. Investors could also demand repayment, which would wipe out most of the remaining runway.
Scenario verdict
The SAFE wins in this scenario because the timeline is uncertain and enterprise sales cycles are unpredictable. If the founders were raising a short bridge with a signed term sheet for a priced round within six months, the convertible note would cost little in interest and would make cautious investors comfortable, so it could become the better choice.
What Are the Total and Hidden Costs of Each?
| Cost factor | SAFE | Convertible Note |
|---|---|---|
| Upfront legal cost | Lower; standard templates exist | Higher; more negotiable terms |
| Recurring cost | None | Interest accrual, commonly 4% to 8% per year (2026) |
| Setup time | Days | Days to weeks |
| Advisory needs | Cap table modeling | Cap table modeling plus debt and maturity review |
| Maintenance | Track outstanding SAFEs and MFN obligations | Track interest, maturity dates, and extensions |
| Switching cost | Low before conversion; investors must consent to changes | Renegotiation at maturity can be costly |
| Opportunity cost | Founder dilution surprises if stacked carelessly | Founder time lost to extension talks |
| Potential upside | Speed, cash preservation, flexibility | Access to cautious investors, clear timelines |
Runway impact rule of thumb: neither instrument burns cash monthly, since note interest is usually paid in shares, not cash. The hidden runway cost of a note shows up only at maturity, when a repayment demand can consume months of runway in a single letter. Treat that as a contingent liability on your financial plan.
Where Does Each Instrument Fail?
Where SAFEs fail
- SAFE stacking: cause, raising many post-money SAFEs; warning sign, you cannot state your fully diluted ownership in one sentence; fix, model every SAFE in a cap table tool before signing.
- Zombie SAFEs: cause, no priced round ever happens; warning sign, profitable company with SAFE holders who own nothing yet; fix, negotiate a conversion path or a buyback with investors early.
- Jurisdiction mismatch: cause, using a US template for an EU entity; warning sign, your notary or lawyer looks confused; fix, use a local equivalent.
- Uncapped SAFE with MFN chaos: cause, giving later investors better terms; warning sign, early investors demand upgrades; fix, standardize terms per round.
Where convertible notes fail
- Maturity cliff: cause, round delayed past maturity; warning sign, six months to maturity with no lead investor; fix, negotiate long maturities (24 months or more) and automatic conversion clauses upfront.
- Interest creep: cause, long delays; warning sign, the converting amount grows faster than your valuation; fix, keep interest at the low end of the 4% to 8% range.
- Creditor pressure: cause, debt status gives holders leverage in distress; warning sign, investors mention repayment; fix, include conversion-at-maturity terms.
- Balance sheet optics: cause, liabilities on your books; warning sign, banks or grant bodies flag your debt ratio; fix, explain the instrument clearly in your financial notes.
Which parts of this decision are reversible?
Very little is reversible once money lands. Both instruments create legal obligations that need investor consent to change. The dilution they produce at conversion is permanent. What you CAN adjust is how you structure the next check: switching from notes to SAFEs, or moving to a priced round, is always possible for new money. Treat the first instrument you sign as a template your future investors will try to copy.
Which Instrument Fits Which Founder Type?
| Founder or startup type | Better default | Why | Watch out for |
|---|---|---|---|
| Bootstrapped startup taking a first check | SAFE | No repayment risk on thin cash | Zombie SAFE if you never raise again |
| VC-track startup | SAFE | Standard for US seed funds and accelerators | Stacking dilution |
| Solopreneur or freelancer turning a business into a startup | SAFE or wait | Avoid personal stress from debt deadlines | Raising before you know you need capital |
| Non-technical founder | SAFE | Fewer terms to misunderstand | Signing without modeling conversion |
| Technical founder | Either | Can model both scenarios quickly | Over-engineering terms |
| Women-led startup | SAFE with clear cap | Women face documented structural gaps in access to capital and networks; standard terms reduce negotiation asymmetry | Being pushed into investor-friendly notes without counsel |
| EU startup | Local convertible loan or ASA-style instrument | Fits local company law and notary rules | Copy-pasting US templates |
| Company bridging to a signed priced round | Convertible note | Short timeline makes interest minor | Round falling through before maturity |
A note on the women-led row: this is not about risk appetite or ability. Through Fe/male Switch, I see capable women founders accept worse terms because they had fewer people to ask. As I keep saying, “Women do not need more inspiration; they need infrastructure.” Standard templates, a cap table model, and one experienced reviewer are infrastructure.
Can European Founders Use a SAFE?
This is the section most US-written guides skip, and it is where I have the strongest opinion. The SAFE was designed for Delaware C-Corps. It assumes US corporate law, US securities rules, and an easy share issuance process. European company law works differently.
- Netherlands and Germany: issuing shares in a BV or GmbH involves a notarial deed. Convertible loans (in German, the Wandeldarlehen) are common and familiar to local angels.
- United Kingdom: founders often use an Advance Subscription Agreement (ASA), partly because SEIS and EIS tax relief has strict rules that a US SAFE may not meet.
- France: the BSA AIR was created as a local SAFE-style instrument.
- Grants and subsidized loans: many EU and national programs look at your balance sheet. A convertible loan shows up as debt, which can matter for some eligibility tests.
- Cross-border investors: a US investor in a European company may push for a Delaware flip. That decision has tax and legal costs that dwarf the SAFE vs note question.
Transferability note: the interest ranges, discounts, and tax figures in this article come from US sources. They are useful reference points, not European market data. When my ventures went through programs such as Yes!Delft, StartupLeap, and Investor Readiness BOM, the first question from experienced advisers was always about the entity and the jurisdiction, never about the template.
Can You Combine a SAFE and a Convertible Note?
Yes, and plenty of startups end up with both on their cap table. The question is whether it helps or adds clutter.
- Sequence: start with SAFEs for friends, angels, and accelerators, then use a short convertible note as a bridge once a priced round is close.
- Segment: offer SAFEs to US investors and a local convertible loan to European angels, with matching caps.
- Experiment: skip the binary entirely and run a small priced round if you already have traction and a lead investor.
Coordination cost: mixing instruments means different conversion mechanics, different seniority, and harder cap table math. Only combine them if a specific investor or jurisdiction requires it.
When Should You Choose a SAFE?
- Choose a SAFE if your company is a US C-Corp and your investors know YC templates.
- Choose a SAFE if your time to a priced round is uncertain or longer than 18 months.
- Choose a SAFE if your cash is thin and a repayment demand would kill the company.
- Choose a SAFE if you want to close small checks fast, on standard terms.
- Avoid a SAFE if you cannot or will not model post-money dilution before each new check.
When Should You Choose a Convertible Note?
- Choose a convertible note if your lead investor refuses to invest without creditor protection.
- Choose a convertible note if you are bridging to a priced round expected within 6 to 12 months.
- Choose a convertible note if you operate in a European jurisdiction where convertible loans are the local standard.
- Choose a convertible note if a clear maturity date helps keep everyone, including you, disciplined.
- Avoid a convertible note if your timeline is unpredictable or the maturity date sits under 18 months.
When Should You Choose Both, or Neither?
- Both: when two investor groups in two jurisdictions need different paperwork, and you can match the economic terms.
- Postpone: when you cannot explain what the money buys in the next 12 months. Raising without a plan only adds pressure.
- Third alternative: grants, revenue-based financing, or customer prepayments. As a European founder, I have seen non-dilutive grants fund early R&D far better than angel money for deeptech.
- Wrong problem: if you are debating instruments instead of talking to customers, the instrument is not your problem.
How Do You Decide Using a Repeatable Framework?
The FITS framework
- Fit: Which instrument matches your entity, jurisdiction, investors, and stage?
- Investment: How much legal cost, founder time, and modeling does each require?
- Trade-offs: Are you trading dilution for investor comfort, or flexibility for discipline?
- Switching: What happens at maturity, at stacking, or if no priced round comes?
Weighted scorecard (example weights)
The weights and scores below are my editorial example for a US pre-seed startup with an uncertain timeline. Replace them with your own.
| Criterion | Weight (1, 5) | SAFE score | Note score |
|---|---|---|---|
| Dilution at conversion | 5 | 4 | 3 |
| Downside and default risk | 5 | 5 | 2 |
| Speed and legal cost | 3 | 5 | 3 |
| Investor appetite | 4 | 4 | 4 |
| Jurisdiction fit | 4 | 5 | 4 |
| Weighted total | 92 | 63 |
Change one input and watch the result move. For a Dutch BV with local angels, jurisdiction fit flips (SAFE 2, note 5) and investor appetite shifts toward notes. The gap closes fast. Treat the score as a thinking aid, not a verdict from the sky.
How Can You Validate Your Choice in 30 Days?
You cannot A/B test a financing instrument. You can run scenario analysis, reference calls, and explicit downside limits. Here is the plan I would give a player inside the Fe/male Switch startup game.
- Define the job: write one sentence on what this money must achieve and by when.
- Set success criteria: maximum acceptable dilution at Series A, minimum months of runway, and time to close.
- Set guardrails: no maturity under 24 months, no interest above 8%, no stacking beyond a set total.
- Model both: build a spreadsheet with three Series A scenarios (early, on time, 12 months late) and run both instruments through them.
- Make reference calls: ask three founders who raised in your jurisdiction what they used and what surprised them.
- Get one legal review: a local startup lawyer for one hour costs far less than one bad clause.
- Set a review date: revisit your instrument choice before every new check and at 90 days.
What Are the Most Common Mistakes to Avoid?
- Signing a SAFE without modeling post-money dilution. Your ownership shrinks with every additional SAFE.
- Accepting a 12-month maturity on a note. Rounds almost never close as fast as you hope.
- Using a US SAFE template for a European company. It may be unenforceable or tax-hostile.
- Negotiating the cap and ignoring the discount, MFN, and pro rata side letters.
- Forgetting that interest converts into equity. 6% sounds small until it turns into 9% more shares.
- Treating “standard” as “fair.” Standard templates protect speed, not you.
Frequently Asked Questions About SAFE vs Convertible Note
Is a SAFE debt?
No. A SAFE is a contractual right to receive future equity. It has no interest, no maturity date, and no repayment obligation.
What interest rate do convertible notes carry in 2026?
Convertible notes commonly carry 4% to 8% annual interest in 2026. The interest usually converts into equity alongside the principal rather than being paid in cash.
Which is better for founders, a SAFE or a convertible note?
For most US pre-seed founders, a SAFE is more founder-friendly because it avoids interest and maturity risk. A convertible note fits bridge rounds and jurisdictions where convertible loans are the local norm.
Where can I find current pre-seed deal term data?
Carta publishes recurring market reports, including the State of Pre-Seed Q2 2026, covering valuation caps and deal terms. Start with Carta’s guide to convertible securities, which links to that data.
What Is the Final Recommendation?
For early-stage founders, choose a SAFE when you run a US entity and your path to a priced round is uncertain. Choose a convertible note when your investors require debt protection and you are bridging to a round expected within a year, or when your European jurisdiction makes convertible loans the natural fit. If your jurisdiction question remains unresolved, settle that first with a local lawyer before comparing templates. Reassess every time you take a new check, change entities, or approach a priced round.
My Mean CEO rule: “Treat your cap table like a game board. Every piece you place early limits the moves you can make later.” Play it deliberately.
Next step: open a spreadsheet today and spend 45 minutes modeling your planned raise as a SAFE and as a convertible note at 6% interest, with your Series A arriving on time, 6 months late, and 12 months late. Write down your ownership in each case. That one table will tell you more than any template ever will.
FAQ on SAFE vs Convertible Note Decisions in 2026
What valuation cap is typical for a pre-seed SAFE in 2026?
For non-AI startups, median post-money caps run about $6M, $10M at pre-seed and $10M, $15M at seed. AI companies often get caps two to three times higher. Benchmark against your own sector rather than headline deals. SAFE legal costs ($0, $2K) also come in well below those for notes ($3K, $10K). Review the latest SAFE note statistics
How can I defend my valuation cap when investors push back?
Run at least three valuation methods, such as Berkus, Scorecard, and the VC Method. Then set your cap where the results overlap. Put your assumptions, comparable deals, and current cap table in a one-page memo. That keeps the negotiation focused on evidence instead of gut feeling. Use the startup valuation methodology SOP
Does signing a SAFE freeze a dynamic co-founder equity split?
It does only if you agree that it does. Under the Slicing Pie model, outside funding is often treated as a freeze trigger that locks contributions into fixed percentages. Decide in writing, before the first check, whether a SAFE counts. Otherwise your investors may inherit a disputed cap table. Read the Slicing Pie handbook summary
Is an insider SAFE better than third-party bridge debt?
Often, yes. A SAFE or note from your existing investors usually closes faster, needs no collateral, and keeps terms consistent with your cap table. A bridge only pays off if it gets you to a real milestone, though. Using it to cover churn or weak product-market fit just buys expensive hope. Explore startup bridge financing alternatives
Do I need a lead investor for a SAFE round?
Rarely. A lead investor matters most in a priced round, where someone has to set terms and often takes a board seat. A SAFE round can close one angel check at a time. Still, a credible anchor investor speeds up follow-on commitments, so try to land one early. Build your lead investor strategy
Can a convertible loan hurt my eligibility for European grants?
It can, because grant bodies may count it as debt in solvency or "undertaking in difficulty" tests. In Germany and similar jurisdictions, founders often add a qualified subordination clause so the loan ranks behind other creditors. Consult your lawyer and grant adviser together before signing. Navigate EU funding with the European Startup Playbook
How should a SAFE appear on my financial statements?
"Not debt" does not mean "not a liability." Under US GAAP, many accountants classify post-money SAFEs as liabilities measured at fair value, because they can be settled in cash during a liquidity event. Raise this with your accountant before due diligence so investors and lenders aren't surprised. Understand SAFE and convertible note accounting
When does the capital gains holding period start for SAFE investors?
This is unsettled. Some US tax advisers argue a SAFE can be treated as equity, which could start the holding period at purchase, including for QSBS purposes. For convertible notes, the holding period generally starts only at conversion. Investors who care about tax-efficient exits will ask, so get written tax guidance. Compare investor tax treatment of SAFEs and notes
What happens to a SAFE or note if my startup is acquired before a priced round?
A standard post-money SAFE pays the holder the greater of their purchase amount or what they would receive by converting at the cap. Convertible notes often include a change-of-control premium, commonly 1x to 2x principal. Review these clauses before acqui-hire talks, because they directly reduce what founders take home. See Carta's convertible securities guide
When should I stop raising on SAFEs and switch to a priced round?
There are no fixed thresholds, but many founders switch when outstanding SAFEs approach $1.5M, $2M, when post-conversion investor ownership nears 20%, or when a lead investor wants governance rights. A priced round costs more in legal fees. In return, it clarifies ownership, removes the SAFE overhang, and signals maturity to later investors. Compare SAFEs, notes, and priced rounds
People Also Ask:
Are convertible bonds the same as convertible notes?
No. Both are debt that can turn into equity, but they serve different markets. Convertible bonds are usually issued by established or publicly traded companies, raise large sums, carry longer maturities, and often trade on secondary markets. Convertible notes are short-term private loans that early-stage startups use to raise seed money before a priced round. They usually convert into preferred stock at the next financing, often with a valuation cap or discount.
What happens if a SAFE never converts?
A SAFE has no maturity date, so it can stay outstanding indefinitely if the startup never raises a qualifying equity round. The company has no obligation to repay the investment. Under the standard Y Combinator SAFE:
- If the company is acquired: The investor typically receives either their original investment back or the value of the shares they would have received on conversion, whichever is greater.
- If the company winds down: SAFE holders may recover part of their money from any remaining assets. They rank behind creditors but ahead of common stockholders.
- If the company keeps operating without raising a round or exiting: The investor may wait years with no return.
What are convertible debt securities?
Convertible debt securities are loans or bonds that the holder can exchange for a set number of the issuer's shares under defined conditions. Common types include convertible bonds, convertible debentures, and convertible notes. They pay interest like regular debt and offer upside if the company's equity value rises. In exchange for the conversion feature, they usually pay lower interest than standard debt.
Are convertible notes usually secured?
Most startup convertible notes are unsecured. They are not backed by specific company assets, and they often rank below senior lenders such as banks. Secured notes do appear in some situations, such as bridge financings for struggling companies or deals where investors want extra protection. In those cases, the note is tied to company assets as collateral.
What is the main difference between a SAFE and a convertible note?
The biggest difference is legal structure. A convertible note is debt. It carries an interest rate, has a maturity date, and creates a legal obligation to repay or convert. A SAFE is not debt. It is a contractual right to future equity, with no interest, no maturity date, and no repayment requirement. Both delay setting a valuation until a later priced round.
Do SAFEs accrue interest?
No. SAFEs do not carry an interest rate, so the investor's conversion amount stays equal to the original investment. Convertible notes accrue interest, typically between 2% and 8% per year. That accrued interest usually converts into extra shares along with the principal, which gives note holders a slightly larger equity stake at conversion.
What happens when a convertible note reaches maturity?
If a note reaches its maturity date, often 18 to 24 months after issuance, before a qualifying round occurs, the company and investors have a few options:
- Repay: The company pays back the principal plus accrued interest.
- Extend: Both sides agree to push out the maturity date.
- Convert: The note converts into equity at a preset valuation, if the terms allow it.
Repayment demands can put heavy pressure on a startup with limited cash, which is one reason many founders prefer SAFEs.
What is a valuation cap and a discount?
Both SAFEs and convertible notes use these terms to reward early investors for taking on more risk.
- Valuation cap: A ceiling on the valuation at which the investment converts. If the next round is priced higher, the early investor converts at the lower cap price and gets more shares.
- Discount: A percentage off the share price paid by new investors in the next round, commonly around 10% to 25%.
When an agreement includes both, the investor typically receives whichever produces the better price.
Should a startup choose a SAFE or a convertible note?
A SAFE is often the better fit for pre-seed and seed rounds. It is fast and inexpensive to close using the standard Y Combinator template, and it puts no debt or maturity pressure on a young company. A convertible note makes more sense when investors require debt terms such as interest and a maturity date, or when a company is raising a short-term bridge between larger financing rounds.
How are SAFEs and convertible notes taxed for investors?
Tax treatment differs between the two. SAFE investors may qualify for capital gains treatment when they eventually sell their shares. Interest on convertible notes counts as taxable income, and investors may owe tax on it even if it converts into equity rather than being paid in cash. Tax rules depend on jurisdiction and individual circumstances, so investors should consult a tax advisor before signing either agreement.
